Cardiovascular Risk and Its Presentation in Chronic Kidney Disease
Journal of Clinical Medicine · 27.06.2025 · 14 (13) · 4567
DOI: 10.3390/jcm14134567 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 27.06.2025. Verfasst von Stefan J Schunk und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine IV, Nephrology and Hypertension, Saarland University, 66421 Homburg/Saar, Germany. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Klinikum Bamberg.
Abstract (Originalsprache)
Background/Objectives: Patients with chronic kidney disease (CKD) are associated with a significantly elevated cardiovascular risk. The incidence and prevalence of mediated cardiac disorders and major adverse cardiac events (MACEs), such as heart failure, arrhythmias, acute coronary syndrome (ACS) based on coronary artery disease (CAD), stroke, venous thromboembolism, and peripheral artery disease, are significantly higher in CKD patients as compared with the general population.
Methods
This narrative review summarizes the current clinical understanding, the pathophysiological mechanisms, and the clinical consequences in the context of cardiovascular risk and disease in CKD.
Results
The impact of CKD on mediated cardiovascular disorders and elevated MACE prevalence is complex and multifactorial. The underlying mechanisms involve various traditional cardiovascular risk factors, such as arterial hypertension, smoking, dyslipidemia, and diabetes. Furthermore, CKD-specific molecular and pathophysiological factors, such as chronic inflammation and associated oxidative stress and endothelial cell dysfunction, pro-coagulatory status, uremic toxins and uremic lipids, progressive vascular calcification, and alterations in the regulation of the renin–angiotensin–aldosterone system (RAAS) and sympathetic activation cause an increased cardiovascular risk.
Conclusions
Understanding the complex disease mechanisms between CKD and elevated cardiovascular risk might contribute to optimizing individual patients’ risk stratification and result in individualized diagnostic and treatment strategies via appropriate clinical biomarker application and individualized anti-inflammatory approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine IV, Nephrology and Hypertension, Saarland University, 66421 Homburg/Saar, Germany.
- Department of Nephrology, Hypertension and Rheumatic Disease, Klinikum Bamberg, 96049 Bamberg, Germany.
- Department of Cardiology, Klinikum Bamberg, 96049 Bamberg, Germany.
- Division of Exercise Physiology and Metabolism, BaySpo-Bayreuth Center of Sport Science, University of Bayreuth, 95440 Bayreuth, Germany.
- Interdisciplinary Center of Sportsmedicine Bamberg, Klinikum Bamberg, 96049 Bamberg, Germany.
Förderung
- Klinikum Bamberg
Zitieren
APA
Schunk, S. J., & Zimmermann, P. (2025). Cardiovascular Risk and Its Presentation in Chronic Kidney Disease. Journal of Clinical Medicine, 14(13), 4567. https://doi.org/10.3390/jcm14134567
Vancouver
Schunk SJ, Zimmermann P. Cardiovascular Risk and Its Presentation in Chronic Kidney Disease. Journal of Clinical Medicine. 2025;14(13):4567. doi:10.3390/jcm14134567
BibTeX
@article{Schunk2025,
author = {Schunk, Stefan J and Zimmermann, Paul},
title = {Cardiovascular Risk and Its Presentation in Chronic Kidney Disease},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {13},
pages = {4567},
doi = {10.3390/jcm14134567}
}
EUVIMED